M, O., A, V., R, A., A, N., NA, V., & AR, T. (2025). Effects of sodium-glucose cotransport-2 inhibitors treatment in patients with pulmonary hypertension. Therapeutic advances in respiratory disease, 19, 17534666251351443. https://doi.org/10.1177/17534666251351443
Chicago Style (17th ed.) CitationM, Obeidat, Vignarajah A, Abdel-Razeq R, Nathir A, Vigneswaramoorthy NA, and Tonelli AR. "Effects of Sodium-glucose Cotransport-2 Inhibitors Treatment in Patients with Pulmonary Hypertension." Therapeutic Advances in Respiratory Disease 19 (2025): 17534666251351443. https://doi.org/10.1177/17534666251351443.
MLA (9th ed.) CitationM, Obeidat, et al. "Effects of Sodium-glucose Cotransport-2 Inhibitors Treatment in Patients with Pulmonary Hypertension." Therapeutic Advances in Respiratory Disease, vol. 19, 2025, p. 17534666251351443, https://doi.org/10.1177/17534666251351443.